In this issue:

  • Paris meeting spotlights renewed focus on antibodies
  • Enhancing Antibodies: A Concern for HIV Vaccine Trials?
  • IAVI Task Force on Antibodies
  • IAVI Launches Project to Develop Oral HIV Vaccine
  • Phase II "Prime-Boost" Trial in Brazil, Haiti and Trinidad
  • Report from 3rd Conference on Vaccine Research
  • The View from SmithKline
  • Vaccines, IAVI at Durban
  • Vaccine Briefs